Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
1999-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1a777dc7e03dd6995b618a7a97482af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49a37a03c295cfb9ba8d384b3c668281 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07601fa050e00191b907c65540551114 |
publicationDate |
2000-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1050308-A1 |
titleOfInvention |
Preventives or remedies for vision disorders |
abstract |
A pharmaceutical composition for preventing orntreating visual function disorders caused by ocularncirculatory disorders (for example, ocular hypertension andnglaucoma) and visual function disorders based on ciliaryntension (for example, myopia) whose active component is anvasopressin antagonist. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1338597-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1338597-A4 |
priorityDate |
1998-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |